In This Article:
In a week marked by downside economic surprises and a sharp pullback in major benchmarks, investors are increasingly looking for resilient growth opportunities. Amidst this backdrop, companies with high insider ownership and robust earnings growth often stand out as attractive options due to their potential for strong alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership
| Name | Insider Ownership | Earnings Growth |
| Cettire (ASX:CTT) | 28.7% | 26.7% |
| Gaming Innovation Group (OB:GIG) | 26.7% | 37.4% |
| KebNi (OM:KEBNI B) | 37.8% | 90.4% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 14.4% | 60.9% |
| Global Tax Free (KOSDAQ:A204620) | 18.1% | 72.4% |
| Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
| Adocia (ENXTPA:ADOC) | 11.9% | 63% |
| Plenti Group (ASX:PLT) | 12.8% | 106.4% |
| Vow (OB:VOW) | 31.7% | 97.7% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 74.3% |
Let's take a closer look at a couple of our picks from the screened companies.
Cosan
Simply Wall St Growth Rating: ★★★★★☆
Overview: Cosan S.A. operates in the fuel distribution business with a market capitalization of R$24.59 billion.
Operations: Cosan's revenue segments include Rumo (R$11.70 billion), Moove (R$9.93 billion), Radar (R$743.21 million), Compass (R$17.38 billion), and Raízen (R$220.40 billion).
Insider Ownership: 30.2%
Earnings Growth Forecast: 24.7% p.a.
Cosan has shown strong growth potential with revenue forecasted to grow 31.7% per year, significantly outpacing the Brazilian market's 7.5%. Earnings are also expected to increase by 24.68% annually, reflecting robust profitability prospects despite a recent net loss of BRL 192.18 million in Q1 2024. However, its debt coverage by operating cash flow is concerning and the dividend track record remains unstable.
Krishna Institute of Medical Sciences
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Krishna Institute of Medical Sciences Limited offers medical and healthcare services under the KIMS Hospitals brand in India, with a market cap of ₹171.31 billion.
Operations: Krishna Institute of Medical Sciences Limited generates revenue from providing medical and healthcare services under the KIMS Hospitals brand in India.
Insider Ownership: 34%
Earnings Growth Forecast: 20.1% p.a.
Krishna Institute of Medical Sciences (KIMS) demonstrates solid growth potential with revenue expected to grow 19.3% annually, outpacing the Indian market's 9.9%. Recent Q1 earnings reported revenue of INR 6,930 million and net income of INR 866 million, reflecting consistent year-over-year growth. Although KIMS carries a high level of debt, its earnings are forecasted to grow significantly at over 20% per year, surpassing the broader market's expectations.